Outcomes With Percutaneous Debulking of Tricuspid Valve Endocarditis.
Robert S ZhangUsman AlamMuhammad Haisum MaqsoodYuhe XiaRafael HarariNorma KellerLindsay ElbaumSunil V RaoCarlos L AlviarSubhash BanerjeePublished in: Circulation. Cardiovascular interventions (2023)
Percutaneous debulking is feasible, effective, and safe in treating patients with tricuspid valve infective endocarditis refractory to medical therapy.
Keyphrases
- aortic valve
- mitral valve
- aortic stenosis
- neoadjuvant chemotherapy
- transcatheter aortic valve replacement
- minimally invasive
- ultrasound guided
- radiofrequency ablation
- ejection fraction
- left ventricular
- healthcare
- locally advanced
- stem cells
- lymph node
- type diabetes
- radiation therapy
- squamous cell carcinoma
- skeletal muscle
- metabolic syndrome
- insulin resistance